The QUANTM Irradiation System can generate 68 Ga at record breaking levels. (Courtesy: ARTMS Products) Gallium-68 (68 Ga) is a positron emitter that’s becoming established as a valuable diagnostic ...

Theranostic radiopharmaceuticals are molecules that can safely carry radioactive isotopes inside targeted human tissues and help physicians get accurate images of tumours, allowing them to more ...

BURNABY, British Columbia--(BUSINESS WIRE)--ARTMS Inc. (ARTMS) is pleased to announce the submission of a Drug Master File (DMF) to the FDA for the high-volume production of Gallium-68 (68 Ga) with ...

BURNABY, British Columbia--(BUSINESS WIRE)--ARTMS Inc. (ARTMS) is pleased to announce the production of Ga-68 Chloride using a medical cyclotron in a US based commercial nuclear pharmacy. The ...

Comparison of concurrent chemoradiation with stereotactic body radiation therapy versus conventionally fractionated radiation therapy following induction chemotherapy for unresected locally advanced ...

Getty Images Ga 68 PSMA-11 PET can detect sites of local recurrence or metastasis in patients with biochemical evidence of recurrent prostate cancer. The FDA has approved gallium 68 PSMA-11 (Ga 68 ...

BURNABY, British Columbia--(BUSINESS WIRE)-- ARTMS Inc. (ARTMS), the global leader in developing and commercializing novel products enabling cyclotron production of the world’s most needed medical ...

Detection of prostate cancer and its recurrence is challenging as it is a heterogeneous disease and methods such as PET imaging and measurement of biochemical response using prostate specific membrane ...

Impact of PSMA PET/CT on SRT planning: Preliminary results from the randomized phase III trial NCT03582774. Radiographic findings on conventional (CT, 99mTc-HDP) and 68 Ga-citrate PET imaging in the ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved Gallium 68 PSMA-11 as the first drug for PET imaging of prostate-specific membrane ...